RGEDF (Chemical Works of Gedeon Richter) EPS without NRI: $2.29 (TTM As of Dec. 2025)


RGEDF Chemical Works of Gedeon Richter PLC RGEDF
94 GF Score
Price $39.76
GF Value $35.24
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Chemical Works of Gedeon Richter EPS without NRI?

Chemical Works of Gedeon Richter RGEDF +0.30% 94 EPS without NRI is $2.29 as of Dec. 2025. GuruFocus rates RGEDF with a GF Score™ of 94/100 and a GF Value™ of $35.24 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 787 Drug Manufacturers companies, Chemical Works of Gedeon Richter ranks worse than 51.72% on this metric.

Chemical Works of Gedeon Richter's earnings per share without non-recurring items for the three months ended in Dec. 2025 was $0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $2.29.

During the past 12 months, Chemical Works of Gedeon Richter's average earnings per share (NRI) Growth Rate was -6.20% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 8.70% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 16.70% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 25.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Chemical Works of Gedeon Richter's EPS without NRI or its related term are showing as below:

RGEDF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -50.8   Med: 3.3   Max: 128.1
Current: 8.7

During the past 13 years, Chemical Works of Gedeon Richter's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 128.10% per year. The lowest was -50.80% per year. And the median was 3.30% per year.

RGEDF's 3-Year EPS without NRI Growth Rate is ranked worse than
51.72% of 787 companies
in the Drug Manufacturers industry
Industry Median: 9.7 vs RGEDF: 8.70

Chemical Works of Gedeon Richter's EPS (Diluted) for the three months ended in Dec. 2025 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $2.12.

Chemical Works of Gedeon Richter's EPS (Basic) for the three months ended in Dec. 2025 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $2.12.


Chemical Works of Gedeon Richter  (OTCPK:RGEDF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Chemical Works of Gedeon Richter EPS without NRI Related Terms


Chemical Works of Gedeon Richter EPS without NRI Historical Data

* Premium members only.

The historical data trend for Chemical Works of Gedeon Richter's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemical Works of Gedeon Richter EPS without NRI Chart

Chemical Works of Gedeon Richter Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.45 3.13 2.60 4.28 4.02

Chemical Works of Gedeon Richter Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.41 0.00 1.20 1.09 0.00

RGEDF vs ZTS, UTHR, VTRS: EPS without NRI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemical Works of Gedeon Richter PE Ratio without NRI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Chemical Works of Gedeon Richter's PE Ratio without NRI falls into.


RGEDF
94GF Score
Chemical Works of Gedeon Richter PLC RGEDF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemical Works of Gedeon Richter EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $2.29 mean?
Chemical Works of Gedeon Richter (RGEDF) has a EPS without NRI of $2.29 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Chemical Works of Gedeon Richter and its competitors. According to the industry distribution chart, Chemical Works of Gedeon Richter ranks #407 out of 787 companies in the Drug Manufacturers industry, placing it in the top 51.7%.
Is Chemical Works of Gedeon Richter's EPS without NRI too high?
Chemical Works of Gedeon Richter's current EPS without NRI is $2.29. The Drug Manufacturers industry median EPS without NRI is 9.70. Chemical Works of Gedeon Richter's value of $2.29 is 76.4% below this industry median. Based on the distribution chart, Chemical Works of Gedeon Richter ranks #407 out of 787 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's EPS without NRI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chemical Works of Gedeon Richter ranks #407 out of 787 companies for EPS without NRI. This places Chemical Works of Gedeon Richter in the lower half of its industry. The industry median EPS without NRI is 9.70. Chemical Works of Gedeon Richter's value of $2.29 is 76.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Drug Manufacturers company?
The median EPS without NRI among Drug Manufacturers companies is 9.70, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemical Works of Gedeon Richter's current EPS without NRI of $2.29 is 76.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Chemical Works of Gedeon Richter and its competitors. For the Drug Manufacturers industry, the median EPS without NRI is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemical Works of Gedeon Richter's current EPS without NRI is $2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (RGEDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $35.24, compared to a current price of $39.76 — trading 12.8% above its estimated fair value. The current EPS without NRI is $2.29 and 76.4% below the Drug Manufacturers industry median of 9.70. Chemical Works of Gedeon Richter's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (RGEDF), the current EPS without NRI is $2.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemical Works of Gedeon Richter (RGEDF) Overvalued in 2026?

Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued. The current stock price of $39.76 is trading 12.8% above its estimated GF Value™ of $35.24. GuruFocus considers Chemical Works of Gedeon Richter to be Modestly Overvalued.

Key valuation signals for RGEDF:

  • EPS without NRI: $2.29
  • GF Value™: $35.24 vs. price of $39.76 (12.8% above fair value)
  • GF Score™: 94/100 with 5 warning signs
  • Industry Position: 76.4% below the Drug Manufacturers median (#407 of 787)

No single metric tells the full story. See the RGEDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chemical Works of Gedeon Richter Business Description

Address Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
94GF Score

Get the complete analysis for RGEDF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.76
Price
$35.24
GF Value